Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

27.77 +0.73 (+2.70%)

Official Closing Price Updated: 7:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	12,585,269
Open	27.48
Bid (Size)	27.50 (100)
Ask (Size)	27.60 (500)
Prev. Close	27.04
Today's Range	26.86 - 28.94
52wk Range	13.74 - 66.20
Shares Outstanding	191,922,517
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations

July 31, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

2 Growth Stocks with Explosive Upside and 1 That Underwhelm

July 31, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

Via StockStory

Performance

YTD	-16.9%	-16.9%
1 Month	-24.5%	-24.5%
3 Month	+1.8%	+1.8%
6 Month	+5.0%	+5.0%
1 Year	-55.6%	-55.6%

More News

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law

July 30, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

July 30, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

July 30, 2026

From Law Offices of Howard G. Smith

Via Business Wire

2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore

July 30, 2026

Via StockStory

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

July 29, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Hims & Hers Responds to FTC Lawsuit

July 29, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

July 24, 2026

Via StockStory

Why Is Hims & Hers Health Stock Surging on Thursday? ↗

July 23, 2026

Via Benzinga

1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds

July 22, 2026

Via StockStory

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 21, 2026

Via Benzinga

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

July 17, 2026

From Hims & Hers

Via Business Wire

3 Reasons HIMS Has Explosive Upside Potential

July 17, 2026

Via StockStory

Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data

July 15, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

July 13, 2026

From Hims & Hers

Via Business Wire

1 Stock Under $50 with Exciting Potential and 2 Facing Challenges

July 13, 2026

Via StockStory

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 06, 2026

Via The Motley Fool

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner ↗

July 06, 2026

Via MarketBeat

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 01, 2026

Via Benzinga

Hims & Hers Stock Surges as Analysts Lift Price Targets ↗

July 01, 2026

Via Benzinga

Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today ↗

June 23, 2026

Via Benzinga

June 23, 2026

Via StockStory

1 Surging Stock Worth Your Attention and 2 We Find Risky

June 22, 2026

Via StockStory

Hims & Hers Stock Jumps After Barclays Raises Price Target ↗

June 18, 2026

Via Benzinga

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?

Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.

What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?

Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?

The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange

What is the current price of Hims & Hers Health, Inc. Class A Common Stock?

The current price of Hims & Hers Health, Inc. Class A Common Stock is 27.77

When was Hims & Hers Health, Inc. Class A Common Stock last traded?

The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 07/31/26 07:00 PM ET

What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?

The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 5.33B

How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?

Hims & Hers Health, Inc. Class A Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.